Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Accured Expenses (2020 - 2025)

Biofrontera (BFRI) has 6 years of Change in Accured Expenses data on record, last reported at $746000.0 in Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 29.42% year-over-year to $746000.0; the TTM value through Sep 2025 reached $1.9 million, up 115.22%, while the annual FY2024 figure was -$230000.0, 96.38% up from the prior year.
  • Change in Accured Expenses reached $746000.0 in Q3 2025 per BFRI's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $11.5 million in Q3 2021 and bottomed at -$12.5 million in Q4 2023.
  • Average Change in Accured Expenses over 5 years is -$219578.9, with a median of $274000.0 recorded in 2023.
  • The widest YoY moves for Change in Accured Expenses: up 11387.5% in 2023, down 1207.09% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at -$12.4 million in 2021, then surged by 109.06% to $1.1 million in 2022, then crashed by 1207.09% to -$12.5 million in 2023, then soared by 96.84% to -$394000.0 in 2024, then soared by 289.34% to $746000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $746000.0 in Q3 2025, $1.2 million in Q2 2025, and $307000.0 in Q1 2025.